Maryland Oncology Hematology P.A. is a clinical research site located in Germantown, Maryland, United States 20876.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Maryland Oncology Hematology P.A. has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Maryland Oncology Hematology P.A. has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Maryland Oncology Hematology P.A. has 2 clinical trials on record, with 2 currently active. Their work covers Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma.
Maryland Oncology Hematology P.A. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.